The most widespread type of liver cancer, HCC, is associated with disabled cellular death
pathways. Despite therapeutic advancements, resistance to current systemic treatments …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths
worldwide. There are two major challenges for HCC, the first being that early detection is …

Hepatocellular carcinoma (HCC) is a highly morbid condition with lack of effective treatment
options. HCC arises from chronically inflamed and damaged liver tissue; therefore …

Background Cell division cycle‐associated 8 (CDCA8) is involved in numerous signaling
networks, and it serves a crucial modulatory function in multiple malignant tumors. However …

Branched-chain amino acids (BCAA) reverse malnutrition and l-carnitine leads to the
reduction of hyperammonemia and muscle cramps in cirrhotic patients. BCAA and l-carnitine …

Lung adenocarcinoma (LUAD), the most common histological type in lung cancer, is one of
leading cancers with considerable morbidity/mortality worldwide. Treating LUAD remains an …

High‐temperature requirement protein A2 (HtrA2), a mitochondrial protein, is related to
apoptosis regulation. However, the role of HtrA2 in hepatocellular carcinoma (HCC) remains …

Background & aims Obesity is a major cause of non-alcoholic fatty liver disease (NAFLD).
NAFLD is an epidemic affecting nearly 34% of the adult population in the US. As a chronic …

Purpose: Chronic inflammation and lipid peroxidation (LPO) are associated with the
pathogenesis of hepatocellular carcinoma (HCC), and γ-hydroxy-1, N 2 …

Epigenetic biomarkers help predict the prognosis of cancer patients and evaluating the
clinical outcome of immunization therapy. In this study, we present a personalized gene …